Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Heart Failure NYHA Class II”

74 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 74 results

Not applicableStudy completedNCT06778330
What this trial is testing

The Effect of Combination of Dapagliflozin and Sildenafil in Treatment of Heart Failure Patients With Secondary Pulmonary Hypertension

Who this might be right for
Heart Failure NYHA Class II
Fayoum University 100
Not applicableUnknownNCT03229681
What this trial is testing

Baduanjin Exercise for Patients With Chronic Heart Failure on Phase II Cardiac Rehabilitation

Who this might be right for
Rehabilitation With CHF; NYHA Class I or II
Xiyuan Hospital of China Academy of Chinese Medical Sciences 120
Not applicableNot Yet RecruitingNCT07065578
What this trial is testing

Optimization of STAR

Who this might be right for
Heart Failure NYHA Class IIHeart Failure NYHA Class III
UMC Utrecht 320
Not applicableUnknownNCT05487365
What this trial is testing

Implementation and Cost-evaluation of a Smartphone-based Telemonitoring and Digital Support in Patients With HF

Who this might be right for
Heart FailureHeart Failure NYHA Class IIHeart Failure NYHA Class III+1 more
Comunicare Solutions SA 330
Testing effectiveness (Phase 2)WithdrawnNCT03005184
What this trial is testing

Mechanism(s) Underlying Cardiovascular Effects of ARB/NEP Inhibition - Aim 2

Who this might be right for
Heart Failure NYHA Class IHeart Failure NYHA Class IIHeart Failure NYHA Class III
Vanderbilt University Medical Center
Not applicableLooking for participantsNCT03180320
What this trial is testing

Baduanjin-eight-silken-movement With Self-efficacy Building for Patients With Chronic Heart Failure (BESMILE-HF Study)

Who this might be right for
Heart Failure NYHA Class IIHeart Failure NYHA Class IIIHeart Failure
Guangdong Provincial Hospital of Traditional Chinese Medicine 150
Not applicableLooking for participantsNCT04829617
What this trial is testing

Promoting Well-being and Health in Heart Failure

Who this might be right for
Heart FailureHeart Failure NYHA Class IHeart Failure NYHA Class II+1 more
Massachusetts General Hospital 280
Testing effectiveness (Phase 2)Active Not RecruitingNCT05384847
What this trial is testing

Effects of Triiodothyronine (T3) in Ischemic Heart Failure

Who this might be right for
Heart Failure
Emory University 20
Not applicableActive Not RecruitingNCT06270875
What this trial is testing

Addressing Pain Through Navigator-Led Palliative Care Optimized for Heart Failure (ADAPT-HF)

Who this might be right for
Chronic IllnessNYHA Class II-IV Heart Failure
University of Alabama at Birmingham 10
Not applicableLooking for participantsNCT07232030
What this trial is testing

Barostim-Enabled NEurohormonal Intervention For Improving Treatment of Heart Failure

Who this might be right for
Heart FailureHeart Failure NYHA Class IIHeart Failure NYHA Class III
CVRx, Inc. 2,500
Large-scale testing (Phase 3)Study completedNCT00853658
What this trial is testing

Efficacy and Safety of Aliskiren and Aliskiren/Enalapril Combination on Morbidity-mortality in Patients With Chronic Heart Failure

Who this might be right for
Chronic Heart Failure
Novartis Pharmaceuticals 7,064
Testing effectiveness (Phase 2)Study completedNCT00461058
What this trial is testing

A Comparative Study of Aleglitazar and Actos in Patients With Type 2 Diabetes Mellitus and New York Heart Association (NYHA) Class II Heart Failure.

Who this might be right for
Diabetes Mellitus Type 2
Hoffmann-La Roche 14
Testing effectiveness (Phase 2)Looking for participantsNCT06369298
What this trial is testing

Study of JK07 in Patients With Chronic Heart Failure

Who this might be right for
Heart Failure With Reduced Ejection FractionHeart Failure With Preserved Ejection Fraction
Salubris Biotherapeutics Inc 282
Not applicableStudy completedNCT06641284
What this trial is testing

Gender-Based Differences in Heart Failure Hospitalizations Among Patients With Heart Failure Treated With Spironolactone

Who this might be right for
Heart FailureHeart Failure With Reduced Ejection FractionHeart Failure NYHA Class II+2 more
Ahmad Abdullah Salawi 509
Not applicableEnrolling By InvitationNCT05255172
What this trial is testing

Exercise Intervention in Patients With Heart Failure With Preserved and Reduced Ejection Fraction

Who this might be right for
Heart Failure New York Heart Association (NYHA) Class IIHeart Failure New York Heart Association (NYHA) Class III
Region Skane 120
Large-scale testing (Phase 3)Study completedNCT00063687
What this trial is testing

Oxypurinol Compared With Placebo for Class III-IV NYHA Congestive Heart Failure

Who this might be right for
Congestive Heart Failure
Advanz Pharma 400
Not applicableStudy completedNCT06233695
What this trial is testing

Gender-based Differences in the Outcome of Treatment With Aldosterone Antagonists in Patients With Heart Failure

Who this might be right for
Heart FailureHeart Failure With Reduced Ejection FractionHeart Failure NYHA Class II+2 more
Alexandria University 100
Not applicableStudy completedNCT03424265
What this trial is testing

Nutritional Therapy Interventions in Heart Failure

Who this might be right for
Heart Failure NYHA Class II
University of Arkansas 63
Not applicableStudy completedNCT01900600
What this trial is testing

Interleukin-1 Blockade With Canakinumab to Improve Exercise Capacity in Patients With Chronic Systolic Heart Failure and Elevated High Sensitivity C-reactive Protein (Hs-CRP)

Who this might be right for
Prior Acute Myocardial InfarctionEvidence of Systemic Inflammation (C Reactive Protein Plasma >2 mg/l)Reduced Left Ventricle Ejection Fraction (<50%)+1 more
Virginia Commonwealth University 15
Testing effectiveness (Phase 2)Ended earlyNCT00283361
What this trial is testing

ZP120 Add-on to Furosemide in Treatment of Acute or Sub-Acute Decompensated Heart Failure

Who this might be right for
Heart Failure, Congestive
Zealand Pharma 130
Load More Results